PMC:7405836 / 86512-87864
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T286 | 6-13 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T287 | 111-115 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T288 | 143-151 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T289 | 285-292 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T290 | 615-623 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T291 | 694-702 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T292 | 914-922 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T293 | 949-956 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T294 | 1032-1037 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T295 | 1138-1146 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T296 | 1255-1263 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T119 | 1032-1037 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T808 | 87-95 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T809 | 87-91 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T810 | 707-715 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T811 | 707-711 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T812 | 1038-1046 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T813 | 1038-1042 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T814 | 1150-1158 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T815 | 1150-1154 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T816 | 1267-1275 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T817 | 1267-1271 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T818 | 1337-1345 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T810 | 20-21 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T811 | 109-115 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T-cell |
| T812 | 236-237 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T813 | 254-259 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T814 | 419-424 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T815 | 433-434 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T816 | 566-571 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T817 | 746-749 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T818 | 787-788 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T819 | 815-820 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T820 | 903-907 | http://purl.obolibrary.org/obo/CLO_0007653 | denotes | M, E |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T23744 | 6-13 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T92057 | 285-292 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T98104 | 364-375 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
| T52094 | 615-623 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T6277 | 694-702 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T15218 | 914-922 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T97166 | 949-956 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T6496 | 1078-1099 | Chemical | denotes | Antigenic determinant | http://purl.obolibrary.org/obo/CHEBI_53000 |
| T76079 | 1138-1146 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T93702 | 1255-1263 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T57 | 143-162 | http://purl.obolibrary.org/obo/GO_0002377 | denotes | antibody production |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T604 | 0-169 | Sentence | denotes | The S protein plays a significant role in the induction of protective immunity against SARS-CoV by mediating T-cell responses and neutralizing antibody production (168). |
| T605 | 170-318 | Sentence | denotes | In the past few decades, we have seen several attempts to develop a vaccine against human coronaviruses by using S protein as the target (168, 169). |
| T606 | 319-460 | Sentence | denotes | However, the developed vaccines have minimal application, even among closely related strains of the virus, due to a lack of cross-protection. |
| T607 | 461-578 | Sentence | denotes | That is mainly because of the extensive diversity existing among the different antigenic variants of the virus (104). |
| T608 | 579-844 | Sentence | denotes | The contributions of the structural proteins, like spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins, of SARS-CoV to induce protective immunity has been evaluated by expressing them in a recombinant parainfluenza virus type 3 vector (BHPIV3). |
| T609 | 845-1077 | Sentence | denotes | Of note, the result was conclusive that the expression of M, E, or N proteins without the presence of S protein would not confer any noticeable protection, with the absence of detectable serum SARS-CoV-neutralizing antibodies (170). |
| T610 | 1078-1214 | Sentence | denotes | Antigenic determinant sites present over S and N structural proteins of SARS-CoV-2 can be explored as suitable vaccine candidates (294). |
| T611 | 1215-1352 | Sentence | denotes | In the Asian population, S, E, M, and N proteins of SARS-CoV-2 are being targeted for developing subunit vaccines against COVID-19 (295). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2421 | 1253-1254 | Gene | denotes | N | Gene:43740575 |
| 2422 | 1243-1244 | Gene | denotes | E | Gene:43740570 |
| 2423 | 1246-1247 | Gene | denotes | M | Gene:43740571 |
| 2424 | 1125-1126 | Gene | denotes | N | Gene:43740575 |
| 2425 | 1240-1241 | Gene | denotes | S | Gene:43740568 |
| 2426 | 1119-1120 | Gene | denotes | S | Gene:43740568 |
| 2427 | 630-635 | Gene | denotes | spike | Gene:43740568 |
| 2428 | 87-95 | Species | denotes | SARS-CoV | Tax:694009 |
| 2429 | 254-259 | Species | denotes | human | Tax:9606 |
| 2430 | 260-273 | Species | denotes | coronaviruses | Tax:11118 |
| 2431 | 707-715 | Species | denotes | SARS-CoV | Tax:694009 |
| 2432 | 801-827 | Species | denotes | parainfluenza virus type 3 | Tax:11216 |
| 2433 | 1150-1160 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 2434 | 1267-1277 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 2435 | 1038-1046 | Species | denotes | SARS-CoV | Tax:694009 |
| 2436 | 677-689 | Gene | denotes | nucleocapsid | Gene:43740575 |
| 2437 | 1337-1345 | Disease | denotes | COVID-19 | MESH:C000657245 |